Journal of the Korean Society of Physical Medicine (대한물리의학회지)

The Korean Society of Physical Medicine (대한물리의학회)
권호 표지
DOI QR코드

DOI QR Code

Analyzing Proportion and Susceptibility Markers of Sarcopenia In Korean Younger Female

  • Received : 2023.09.13
  • Accepted : 2023.10.01
  • Published : 2023.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

PURPOSE: This investigation in the study aimed to assess to determine proportion and susceptibility makers of sarcopenia in Korean younger female aged 30 to 39 years. METHODS: To address the complex sampling design of Korea National Health and Nutrition Examination Surveys, appropriate individual weights were incorporated into the analysis. The data employed a stratified, clustered, multistage probability sampling design. A total of 2,098 participants were enrolled and categorized into two groups based on their skeletal muscle mass index scores. One hundred and twenty-four individuals were placed in the sarcopenia group, while 2,024 were allocated to a normal group. The study examined various markers as variables, including age, height, weight, body mass index waist circumference, skeletal muscle mass index, systolic and diastolic blood pressure, fasting glucose, triglyceride, and total cholesterol levels, and smoking and drinking habits. RESULTS: The study found that proportion of sarcopenia in this population was 3.78% (CI: 2.89-4.94) in sarcopenia group and 96.22% (CI: 95.06-97.11) in normal with weighed values. Several susceptibilities including height, weight, BMI, waist circumference, diastolic blood pressure, and total cholesterol levels were risk factor for sarcopenia (p < .05), exhibited significant differences between the sarcopenia and normal groups. CONCLUSION: This investigation provides the proportion of sarcopenia and identifies relevant susceptibility markers among community dwelling younger women in Korea.

Keywords

References

  1. Population Division, Department of economic and social affairs. United Nations. World population aging. 2019. 11-4. 
  2. Wang C, Bai L. Sarcopenia in the elderly: basic and clinical issues. Geriatr Gerontol Int. 2012;12(3):388-96.  https://doi.org/10.1111/j.1447-0594.2012.00851.x
  3. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127(5 Suppl):990S-1S.  https://doi.org/10.1093/jn/127.5.990S
  4. Jung HW. Visualizing domains of comprehensive geriatric assessments to grasp frailty spectrum in older adults with a radar chart. Ann Geriatr Med Res. 2020; 24(1):55-6.  https://doi.org/10.4235/agmr.20.0013
  5. Dam TT, Peters KW, Fragala M, et al. An evidence-based comparison of operational criteria for the presence of sarcopenia. J Gerontol A Biol Sci Med Sci. 2014;69(5):584-90.  https://doi.org/10.1093/gerona/glu013
  6. Htun NC, Ishikawa-Takata K, Kuroda A, et al. Screening for malnutrition in community dwelling older Japanese: preliminary development and evaluation of the Japanese nutritional risk screening tool (NRST). J Nutr Health Aging. 2016;20(2):114-20.  https://doi.org/10.1007/s12603-015-0555-3
  7. H an K, Park YM, Kwon H S, et al. Sarcopenia as a determinant of blood pressure in older Koreans: findings from the Korea national health and nutrition examination surveys (KNHANES) 2008-2010. PLoS One. 2014;9(1):e86902. 
  8. Cawthon PM, Blackwell TL, Cauley J, et al. Evaluation of the usefulness of consensus definitions of sarcopenia in older men: results from the observational osteoporotic fractures in men cohort study. J Am Geriatr Soc. 2015;63(11):2247-59.  https://doi.org/10.1111/jgs.13788
  9. Pereira FB, Leite AF, de Paula AP. Relationship between pre-sarcopenia, sarcopenia and bone mineral density in elderly men. Arch Endocrinol Metab. 2015;59(1):59-65.  https://doi.org/10.1590/2359-3997000000011
  10. Laurent MR, Dedeyne L, Dupont J, et al. Age-related bone loss and sarcopenia in men. Maturitas. 2019;122:51-6.  https://doi.org/10.1016/j.maturitas.2019.01.006
  11. Reijnierse EM, de van der Schueren MAE, Trappenburg MC, et al. Lack of knowledge and availability of diagnostic equipment could hinder the diagnosis of sarcopenia and its management. PLoS One. 2017;12(10):e0185837. 
  12. Mehiret G, Molla A, Tesfaw A. Knowledge on risk factors and practice of early detection methods of breast cancer among graduating students of Debre Tabor University, Northcentral Ethiopia. BMC Womens Health. 2022;22(1):183. 
  13. Stenholm S, Harris TB, Rantanen T, et al. Sarcopenic obesity-definition, etiology and consequences. Curr Opin Clin Nutr Metab Care. 2008;11(6):693. 
  14. Hashemi R, Shafiee G, Motlagh AD, et al. Sarcopenia and its associated factors in Iranian older individuals: results of SARIR study. Arch Gerontol Geriatr. 2016;66:18-22.  https://doi.org/10.1016/j.archger.2016.04.016
  15. Santos VRd, Araujo MYC, Cardoso MR, et al. Association of insufficient physical activity with sarcopenia and sarcopenic obesity in individuals aged 50 years or more. Revista de Nutricao. 2017;30:175-84.  https://doi.org/10.1590/1678-98652017000200003
  16. Huschtscha Z, Parr A, Porter J, et al. Sarcopenic characteristics of active older adults: a cross-sectional exploration. Sports Med Open. 2021;7(1):32. 
  17. Hwang J, Park S. Gender-specific risk factors and prevalence for sarcopenia among community-dwelling young-old adults. Int J Environ Res Public Health. 2022;19(12):7232. 
  18. Hwang J, Park S. Sex differences of sarcopenia in an elderly asian population: the prevalence and risk factors. Int J Environ Res Public Health. 2022;19(19): 11980. 
  19. Hwang J. Prevalence, anthropometric risk factors, and clinical risk factors in sarcopenic women in their 40s. J Korean Soc Phys Med. 2023;18(2):23-31.  https://doi.org/10.3346/jkms.2003.18.1.23
  20. Hwang J. Age-related loss of skeletal muscle and associated risk factors in middle-aged men: a comprehensive study. J Korean Soc Phys Med. 2023;18(2):13-21.  https://doi.org/10.13066/kspm.2023.18.2.13
  21. Hwang J, Park S. Gender-specific prevalence and risk factors of sarcopenic obesity in the Korean elderly population: a nationwide cross-sectional study. Int J Environ Res Public Health. 2023;20(2):1140. 
  22. Lexell J, Downham D, Sjostrom M. Distribution of different fibre types in human skeletal muscles. Fibre type arrangement in m. vastus lateralis from three groups of healthy men between 15 and 83 years. J Neurol Sci. 1986;72(2-3):211-22.  https://doi.org/10.1016/0022-510X(86)90009-2
  23. Kehayias JJ, Fiatarone MA, Zhuang H, et al. Total body potassium and body fat: relevance to aging. Am J Clin Nutr. 1997;66(4):904-10.  https://doi.org/10.1093/ajcn/66.4.904
  24. Janssen I, Heymsfield SB, Wang ZM, et al. Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. J Appl Physiol (1985). 2000;89(1):81-8.  https://doi.org/10.1152/jappl.2000.89.1.81
  25. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50(5):889-96.  https://doi.org/10.1046/j.1532-5415.2002.50216.x
  26. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31.  https://doi.org/10.1093/ageing/afy169
  27. Hwang J. Unraveling the contributing factors of sarcopenia in young Korean male adults: a study of occurrence, somatometric, biochemical, and behavioral characteristics. J Korean Soc Phys Med. 2023;18(3): 21-30.  https://doi.org/10.13066/kspm.2023.18.3.21
  28. Hwang J. Comprehensive investigation on the prevalence and risk factors of coexistence of age-related loss of skeletal muscle mass and obesity among males in their 40s. J Korean Soc Phys Med. 2023;18(3):1-9.  https://doi.org/10.13066/kspm.2023.18.3.1
  29. Hwang J, Moon IY. Exploring incidence and potential risk factors of sarcopenic obesity among middle-aged women residing in a community. J Korean Soc Phys Med. 2023;18(3):11-9.  https://doi.org/10.13066/kspm.2023.18.3.11
  30. Hwang J, Park S. A Korean nationwide cross-sectional study investigating risk factors, prevalence, and characteristics of sarcopenia in men in early old age. Healthcare. MDPI. 2023. pp.2860. 
  31. Belarmino G, Gonzalez MC, Sala P, et al. Diagnosing sarcopenia in male patients with cirrhosis by dual-energy x-ray absorptiometry estimates of appendicular skeletal muscle mass. JPEN J Parenter Enteral Nutr. 2018;42(1):24-36.  https://doi.org/10.1177/0148607117701400
  32. Sanada K, Miyachi M, Tanimoto M, et al. A cross-sectional study of sarcopenia in Japanese men and women: reference values and association with cardiovascular risk factors. Eur J Appl Physiol. 2010;110(1):57-65.  https://doi.org/10.1007/s00421-010-1473-z
  33. Brown JC, Harhay MO, Harhay MN. Sarcopenia and mortality among a population-based sample of community-dwelling older adults. J Cachexia Sarcopenia Muscle. 2016;7(3):290-8.  https://doi.org/10.1002/jcsm.12073
  34. Confortin SC, Meneghini V, Ono LM, et al. Anthropometric indicators as a screening tool for sarcopenia in older adults from Florianopolis, Santa Catarina: EpiFloripa Ageing study. Revista De Nutricao-Brazilian Journal of Nutrition. 2017;30(3): 287-96.  https://doi.org/10.1590/1678-98652017000300002
  35. Zamboni M, Mazzali G, Fantin F, et al. Sarcopenic obesity: a new category of obesity in the elderly. Nutr Metab Cardiovasc Dis. 2008;18(5):388-95.  https://doi.org/10.1016/j.numecd.2007.10.002
  36. Nair KS. Aging muscle. Am J Clin Nutr. 2005;81(5):953-63.  https://doi.org/10.1093/ajcn/81.5.953
  37. Cesari M, Kritchevsky SB, Baumgartner RN, et al. Sarcopenia, obesity, and inflammation--results from the trial of angiotensin converting enzyme inhibition and novel cardiovascular risk factors study. Am J Clin Nutr. 2005;82(2):428-34.  https://doi.org/10.1093/ajcn/82.2.428
  38. Du Y, Wang X, Xie H, et al. Sex differences in the prevalence and adverse outcomes of sarcopenia and sarcopenic obesity in community dwelling elderly in East China using the AWGS criteria. BMC Endocr Disord. 2019;19(1):109. 
  39. Cleasby ME, Jamieson PM, Atherton PJ. Insulin resistance and sarcopenia: mechanistic links between common co-morbidities. J Endocrinol. 2016;229(2):R67-81.  https://doi.org/10.1530/JOE-15-0533
  40. Schrager MA, Metter EJ, Simonsick E, et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol (1985). 2007;102(3):919-25.  https://doi.org/10.1152/japplphysiol.00627.2006
  41. Lu CW, Yang KC, Chang HH, et al. Sarcopenic obesity is closely associated with metabolic syndrome. Obes Res Clin Pract. 2013;7(4):e301-7.  https://doi.org/10.1016/j.orcp.2012.02.003
  42. Atkins JL, Whincup PH, Morris RW, et al. Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men. J Am Geriatr Soc. 2014;62(2):253-60.  https://doi.org/10.1111/jgs.12652
  43. Androga L, Sharma D, Amodu A, et al. Sarcopenia, obesity, and mortality in US adults with and without chronic kidney disease. Kidney Int Rep. 2017;2(2):201-11.  https://doi.org/10.1016/j.ekir.2016.10.008
  44. Yin T, Zhang JX, Wang FX, et al. The association between sarcopenic obesity and hypertension, diabetes, and abnormal lipid metabolism in Chinese adults. Diabetes Metab Syndr Obes. 2021;14:1963-73.  https://doi.org/10.2147/DMSO.S308387
  45. Ferreira I, Snijder MB, Twisk JW, et al. Central fat mass versus peripheral fat and lean mass: opposite (adverse versus favorable) associations with arterial stiffness? the amsterdam growth and health longitudinal study. J Clin Endocrinol Metab. 2004;89(6):2632-9.  https://doi.org/10.1210/jc.2003-031619
  46. Snijder MB, Henry RM, Visser M, et al. Regional body composition as a determinant of arterial stiffness in the elderly: the hoorn study. J Hypertens. 2004;22(12):2339-47.  https://doi.org/10.1097/00004872-200412000-00016
  47. Dominguez LJ, Barbagallo M. The cardiometabolic syndrome and sarcopenic obesity in older persons. J Cardiometab Syndr. 2007;2(3):183-9.  https://doi.org/10.1111/j.1559-4564.2007.06673.x
  48. Goswami B, Reang T, Sarkar S, et al. Role of body visceral fat in hypertension and dyslipidemia among the diabetic and nondiabetic ethnic population of Tripura-A comparative study. J Family Med Prim Care. 2020;9(6):2885-90.  https://doi.org/10.4103/jfmpc.jfmpc_187_20
  49. Therakomen V, Petchlorlian A, Lakananurak N. Prevalence and risk factors of primary sarcopenia in community-dwelling outpatient elderly: a cross-sectional study. Sci Rep. 2020;10(1):19551.